Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
Sponsor: University Hospital Heidelberg
Summary
The study is a randomized, open, prospective phase II study. The aim of the study is to evaluate the safety and feasibility of a hypofractionated, accelerated radiation approach based on the incidence of grade 3-5 NCI Common Terminology Criteria for Adverse Events (NCI-CTC-AE ) toxicity and / or termination of the planned therapy for any reason with neoadjuvant radiation with active beam guidance of the retroperitoneal Sarcomas using protons or carbon ions before a subsequent tumor resection.
Official title: Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion Prospektive Randomisierte Phase-II-Studie
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2019-05-09
Completion Date
2027-05-09
Last Updated
2026-03-10
Healthy Volunteers
No
Conditions
Interventions
Proton radiation
Therapeutic radiation Treatment with Protons
Carbon Ion radiation
Therapeutic radiation Treatment with Carbon Ions
Locations (1)
University Hospital of Heidelberg, Radiation Oncology
Heidelberg, Germany